Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: A provisional biopharmaceutical classification of the list of national essential medicines of Pakistan

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 2, 2011, Pages 83-99

  Shawahna, R ^a   Rahman, N U ^a  

^a University of Bahawalpur   (Pakistan)

Author keywords

Biopharmaceutical classification system; Log D; Log P; Permeability; PSA

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTHELMINTIC AGENT; ANTIALLERGIC AGENT; ANTIAMEBIC AGENT; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIDOTE; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTIRETROVIRUS AGENT; CODEINE; DIURETIC AGENT; LABETALOL; METOPROLOL; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG PENETRATION; EVALUATION; INTESTINE MUCOSA PERMEABILITY; ORAL DRUG ADMINISTRATION; PAKISTAN; PARTITION COEFFICIENT; PREDICTION; SOLUBILITY; SURFACE PROPERTY;

EID: 79958084888     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Qiu Y, Chen Y, Liu L, Zhang G. Developing solid oral dosage forms: pharmaceutical theory and practice. USA, Elsevier Inc. 2009; 341-360.
2. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 1995; 12: 413-420.
3. Cook J, Addicks W, Wu YH. Application of the biopharmaceutical classification system in clinical drug development--an industrial view. AAPS J, 2008; 10: 306-310.
4. Polli JE. In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms. AAPS J, 2008; 10: 289-299.
5. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm, 2004; 1: 85-96.
6. Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res, 1997; 14: 568-571.
7. World Health Organization (WHO). National Essential Medicines List of Pakistan, 2007 (4th Revision) at http://apps.who.int/medicinedocs/fr/m/abstract/Js17119e/ accessed on 14/12/2010.
8. The European Agency for the Evaluation of Medicinal Products (EMA), Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on the Investigation of Bioavailability and Bioequivalence. 2010.
9. Yalkowsky S, He Y. Handbook of aqueous solubility data. Boca Raton, FL. CRC Press. 2003.
10. Drugbank database. http://www.drugbank.ca/ accessed on 14/12/2010.
11. Syracuse Research Corporation. Physical/Chemical Property Database (PHYSPROP). SRC Environmental Science Center. Syracuse, NY. 1994.
12. Block J, Beale J. Wilson & Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. MD. Lippincott Williams and Wilkins. 2004. 948-956.
13. Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classifcation system. Eur J Pharm Biopharm, 2004; 58: 265-278.
14. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. Molecular properties of WHO essential drugs and provisional biopharmaceutical classifcation. Mol Pharm, 2004; 1: 85-96.
15. Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classifcation system: the central role of dose/solubility ratio. Pharm Res, 2003; 20: 1917-1925.
16. World Health Organization (WHO). Proposal to waive in vivo http://whqlibdoc.who.int/trs/WHO_TRS_ 937_eng.pdf.)
17. Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen JP. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res, 1999; 16: 1514-1519.
18. Food and Drug Administration (FDA), CDER. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. Food and Drug Administration, Ed. Rockville, MD. 2000.
19. Valope D. Drug Permeability Studies in Regulatory Biowaiver Applications. In: Ehrhardt C, Kim K, ed. Drug absorption studies: in situ, in vitro and in silico models. Springer NY 2008; 665-696.
20. Linnankoski J, Makela JM, Ranta VP, Urtti A, Yliperttula M. Computational prediction of oral drug absorption based on absorption rate constants in humans. J Med Chem, 2006; 49: 3674-3681.
21. Palm K, Luthman K, Ungell AL, Strandlund G, Beigi F, Lundahl P, Artursson P. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J Med Chem, 1998; 41: 5382-5392.
22. Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernas H, Karlen A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem, 1998; 41: 4939-4949.
23. Box KJ. Comer JE. Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class. Curr Drug Metab, 2008; 9: 869-878.
24. Benet LZ, Larregieu CA. The FDA should eliminate the ambiguities in the current BCS biowaiver guidance and make public the drugs for which BCS biowaivers have been granted. Clin Pharmacol Ther, 2010; 88: 405-407.
25. Transporter Database, TP-Search. http://www.tp-search.jp/ accessed on 14/12/2010.